MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM - Wikidata - wikimedia - TriplyDB

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM

http://www.wikidata.org/entity/Q28285953

about

ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate Regulation and function of the FGF23/klotho endocrine pathways Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia Osteocytes: master orchestrators of bone Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice A unified model for bone-renal mineral and energy metabolism Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4 Asporin and the mineralization process in fluoride-treated rats MEPE is a novel regulator of growth plate cartilage mineralization PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.Identification of two novel mutations in the PHEX gene in Chinese patients with hypophosphatemic rickets/osteomalacia.Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.FGF-23 in bone biology.Different forms of DMP1 play distinct roles in mineralization.Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type.Adaptive evolution of the matrix extracellular phosphoglycoprotein in mammals Surface immobilization of MEPE peptide onto HA/β-TCP ceramic particles enhances bone regeneration and remodeling.Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia Collagen osteoid-like model allows kinetic gene expression studies of non-collagenous proteins in relation with mineral development to understand bone biomineralization The impairment of osteogenesis in bone sialoprotein (BSP) knockout calvaria cell cultures is cell density dependent.SPR4-peptide alters bone metabolism of normal and HYP mice.ASARM mineralization hypothesis: a bridge too far?Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'.Biomineralization of bone: a fresh view of the roles of non-collagenous proteins.Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.Downregulation of PHEX in multibacillary leprosy patients: observational cross-sectional study.The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.Do ASARM peptides play a role in nephrogenic systemic fibrosis?Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.FGF23 production by osteocytes.Endochondral Growth Defect and Deployment of Transient Chondrocyte Behaviors Underlie Osteoarthritis Onset in a Natural Murine Model

P2860

Q24632241-2CF2BB8E-A77D-457F-B547-3722E24A8A45 Q26860470-D752B58A-526E-42C1-AF7F-E6C7F4963BD9 Q26866263-1892F307-CA97-48E7-AC55-BA4CACAD1956 Q27002346-88D6C17E-6495-4F99-9034-DC0D003FF4EB Q27022407-348667E4-93CE-4D75-89F0-F9281A09FE0A Q27026805-8AA19FE9-C114-4198-AE43-AFE883035430 Q27343138-2B208B95-A1D1-427F-BA58-813A6D540B7C Q27690863-FB4041C6-74BB-4F28-96D5-1353365B5390 Q28275381-75F27B0B-E58F-479E-90CE-1D3E6C296FF4 Q28301682-B87DB325-4C15-4ECC-9BBB-5E8358099B9B Q28568733-0F4DBACE-F841-4DEB-947F-BAB23E4C16DD Q28578492-49E434E4-5440-442E-B89F-5AC86FE7E850 Q28593877-E4B56AD3-7239-414D-AF1E-68966B77B627 Q31161423-255554B6-2ACE-445C-A1D9-3143733A920B Q33617326-009F3F33-EB51-41ED-A8F1-4E7192BFBA18 Q33623726-C0A329A9-557F-416F-8F0F-2F2A0440A293 Q33643995-13302114-FB42-4F12-9744-CFD7688158F6 Q33684986-BBA87FE0-07EC-4204-B73A-57D94AAC126B Q33862348-0853B38C-A0F3-4959-9974-3063EC096871 Q34014158-AB62D4C5-B529-42F6-8575-86CD08DD5286 Q34079417-F8325B0E-024C-4047-8385-EEBE31B91D47 Q34249760-BED961D6-0A31-4BDB-98EF-BB19C9F69FFD Q34251323-CACF51A3-FA7F-4A12-81D1-E78152277F44 Q34333904-0AB69D47-A8CF-4670-931D-14385B21F2A8 Q34602567-4B03EC6F-AF6F-44C5-84ED-5DE9D16FC5D4 Q34608502-A66C0C91-3C3D-40F7-B82A-E94C7D2C073B Q35118585-080BF341-E79E-4BAC-89FB-E728D8EB4395 Q35128414-CA5EE0A4-1796-41A7-9FF5-DE2420D57F74 Q35156045-EFD8257A-C386-4351-927B-3468371A793F Q35218561-AA544895-533B-4077-9A83-E78F66DC2597 Q35606605-CADF060F-C663-4A43-96C6-A6893AA3BC04 Q35850452-A0B16172-BE51-4168-B9FD-3E30179E5EF6 Q35920063-0301507E-7C4F-4480-8564-A3FC670C41E9 Q35983181-C08BC3F7-875E-4428-AC67-44C7787ADC5C Q36050157-A3CF7BF5-8BAD-4248-B199-EF9D69AED27E Q36074718-567837B0-86A4-4DFD-98D0-46D1487FF001 Q36237106-9CBDBABE-6050-4D6E-B9D7-082940FC9BF6 Q36367168-0ADC99F7-C594-4865-AF7C-3A55DBD60CE0 Q36639867-E49F4009-1398-40D6-822F-597C2D5912DF Q36800126-A3155AFB-86C6-403A-8EC1-095209788753

P2860

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM

http://www.wikidata.org/entity/Q28285953

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@ast

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@en

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@nl

type

label

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@ast

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@en

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@nl

prefLabel

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@ast

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@en

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@nl

P1433

Q28285953-494394E2-CB19-4316-851A-77E59E9F453D

P1476

Q28285953-09F2AD6E-BC2F-4B01-8D3F-5A02A318F725

P2093

Q28285953-243F3445-C044-4D85-A10B-AC6AA14E5267

Q28285953-5273A1B1-5E99-41C7-B7DC-6E447CDDDC0C

Q28285953-7DEA1E83-56D4-4680-96A3-7FD8785538E3

Q28285953-8E858E65-58F1-4053-AA0B-595245779377

Q28285953-95D5A2A3-0E86-4F81-BA06-5D62CB5C4013

P2860

Q28285953-942128AE-2EEA-4CB6-BAB5-F43B35E78C5D

Q28285953-B21C47F3-5A04-4B20-8587-873F6AC59D53

Q28285953-EE0B937F-9BCB-4179-A995-E19743772B1A

P304

Q28285953-FF643E07-16BC-41AC-B5D9-1375AB41B1D3

P31

Q28285953-B9ADD0BF-54D9-4A81-913C-ECB0B0EA4A0E

P3181

Q28285953-EB484A84-3557-485D-A768-6074D16F5C61

P356

Q28285953-134BD85E-5165-47B1-B60D-262C8DF2A0B9

P407

Q28285953-CFC63FAA-9B99-43C9-BCDF-2DC2F9B07F64

P433

Q28285953-65E726A8-B488-4EE5-B3F6-E13C8C0CDE0F

P478

Q28285953-49B00FD9-024B-4D18-B76B-4C73434ED169

P577

Q28285953-72595F20-1FDC-482B-B407-A249962BFD29

P5875

Q28285953-95B42CCD-9FEB-4523-92FD-017FE92C146A

P698

Q28285953-FFBD2349-DBCA-416E-A264-E23F966BAED7

P921

Q28285953-6CD2130D-6479-4571-BA93-5C9F9F7A528F

P3181

P356

P1433

Journal of Bone and Mineral Research

P1476

MEPE-ASARM peptides control ex ...... ated by PHEX cleavage of ASARM

@en

P2093

Marc D McKee

http://www.w3.org/2001/XMLSchema#string

Phillippe Crine

http://www.w3.org/2001/XMLSchema#string

Thomas Loisel

http://www.w3.org/2001/XMLSchema#string

William N Addison

http://www.w3.org/2001/XMLSchema#string

Yukiko Nakano

http://www.w3.org/2001/XMLSchema#string

P2860

Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins

Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation

Biomineralization: An Overview

P304

1638-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4944778

http://www.w3.org/2001/XMLSchema#string

P356

10.1359/JBMR.080601

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5255025

http://www.w3.org/2001/XMLSchema#string

P698

18597632

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix